Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Lawrence D Phillips

Showing results (1-10 of 24) with videos related to

Pageof 3
Sort By:
British Journal of Clinical Pharmacology|June 13, 2020
Advancing structured decision-making in drug regulation at the FDA and EMAAris Angelis, Lawrence D Phillips
Value in Health : the Journal of the International Society for Pharmacoeconomics and Outcomes Research|August 24, 2020
ICER Value Framework 2020 Update: Recommendations on the Aggregation of Benefits and Contextual ConsiderationsAris Angelis, Panos Kanavos, Lawrence D Phillips
British Journal of Clinical Pharmacology|July 17, 2023
Bayesian analysis of real-world data as evidence for drug approval: Remembering Sir Michael RawlinsBalázs Szigeti, Lawrence D Phillips, David Nutt
Risk Analysis : an Official Publication of the Society for Risk Analysis|January 31, 2009
Nuclear risk management on stage: a decision analysis perspective on the UK's Committee on Radioactive Waste ManagementAlec Morton, Mara Airoldi, Lawrence D Phillips
Therapeutic Innovation & Regulatory Science|September 21, 2018
Structured Approaches to Benefit-Risk Assessment: A Case Study and the Patient PerspectiveBennett Levitan, Lawrence D Phillips, Stuart Walker
Lancet (London, England)|November 2, 2010
Drug harms in the UK: a multicriteria decision analysisDavid J Nutt, Leslie A King, Lawrence D Phillips, et al.
BMJ Open|September 22, 2020
So near yet so far: why won't the UK prescribe medical cannabis?David Nutt, Steve Bazire, Lawrence D Phillips, et al.
Clinical Pharmacology and Therapeutics|April 1, 2019
Quantifying Preferences in Drug Benefit-Risk DecisionsTommi Tervonen, Aris Angelis, Kimberley Hockley, et al.
Medical Decision Making : an International Journal of the Society for Medical Decision Making|March 13, 2013
Risk perception of prescription drugs: results of a survey among experts in the European regulatory networkAndrea R Beyer, Barbara Fasolo, Lawrence D Phillips, et al.
Frontiers in Psychiatry|November 21, 2022
The value of real world evidence: The case of medical cannabisAnne Katrin Schlag, Rayyan R Zafar, Michael T Lynskey, et al.
Pageof 3

Showing results (1-10 of 24) with videos related to

Sort By:
Pageof 3
British Journal of Clinical Pharmacology|June 13, 2020
Advancing structured decision-making in drug regulation at the FDA and EMAAris Angelis, Lawrence D Phillips
Value in Health : the Journal of the International Society for Pharmacoeconomics and Outcomes Research|August 24, 2020
ICER Value Framework 2020 Update: Recommendations on the Aggregation of Benefits and Contextual ConsiderationsAris Angelis, Panos Kanavos, Lawrence D Phillips
British Journal of Clinical Pharmacology|July 17, 2023
Bayesian analysis of real-world data as evidence for drug approval: Remembering Sir Michael RawlinsBalázs Szigeti, Lawrence D Phillips, David Nutt
Risk Analysis : an Official Publication of the Society for Risk Analysis|January 31, 2009
Nuclear risk management on stage: a decision analysis perspective on the UK's Committee on Radioactive Waste ManagementAlec Morton, Mara Airoldi, Lawrence D Phillips
Therapeutic Innovation & Regulatory Science|September 21, 2018
Structured Approaches to Benefit-Risk Assessment: A Case Study and the Patient PerspectiveBennett Levitan, Lawrence D Phillips, Stuart Walker
Lancet (London, England)|November 2, 2010
Drug harms in the UK: a multicriteria decision analysisDavid J Nutt, Leslie A King, Lawrence D Phillips, et al.
BMJ Open|September 22, 2020
So near yet so far: why won't the UK prescribe medical cannabis?David Nutt, Steve Bazire, Lawrence D Phillips, et al.
Clinical Pharmacology and Therapeutics|April 1, 2019
Quantifying Preferences in Drug Benefit-Risk DecisionsTommi Tervonen, Aris Angelis, Kimberley Hockley, et al.
Medical Decision Making : an International Journal of the Society for Medical Decision Making|March 13, 2013
Risk perception of prescription drugs: results of a survey among experts in the European regulatory networkAndrea R Beyer, Barbara Fasolo, Lawrence D Phillips, et al.
Frontiers in Psychiatry|November 21, 2022
The value of real world evidence: The case of medical cannabisAnne Katrin Schlag, Rayyan R Zafar, Michael T Lynskey, et al.
Pageof 3